VTVT · NASDAQ · Biotechnology

vTv Therapeutics (VTVT)

Develops oral small molecules for diabetes, centered on cadisegliatin alongside insulin.

$30.51
vs last close−0.60 (−1.91%)

13F · 13D/G · Form 4

Institutions40.65%1.61M shares
44 holders · as of Jun 30, 2026
Insiders28.88%1.14M shares
4 holders · as of Feb 18, 2026
Strategic holders5.23%206.8K shares
1 holder · as of Dec 6, 2024
Other25.24%998.0K shares
remainder

3.95M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (3.95M in the company's Sep 23, 2026 report, 2.62M elsewhere); stakes use the report.

This company has 2 share classes; every stake here is a share of the whole company.

13F · 13D/G · Form 4

HolderStakeSharesDate
Srinivas Akkaraju1Insiderdirector
10.22%403,942 Afiled Dec 9, 2025
Paul J. SekhriInsiderdirector, officer: Pres, CEO and Exec Chairperson
9.92%392,212 Afiled Feb 18, 2026
Invus Public Equities, L.P.Insider
8.75%345,926filed Nov 12, 2025
Samsara Biocapital, LLCInstitution
7.55%298,496 Aas of Jun 30, 2026
Millennium Management LLCInstitution
6.83%269,874 Aas of Jun 30, 2026
FMR LLCInstitution
6.59%260,391 Aas of Jun 30, 2026
Samsara BioCapital GP, LLCStrategic10 percent owner
5.23%206,784 Afiled Dec 6, 2024
Siren, L.L.C.Institution
4.12%163,000 Aas of Jun 30, 2026
Baker Bros. Advisors LPInstitution
3.75%148,314 Aas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
2.39%94,463 Aas of Jun 30, 2026
Trails Edge Capital Partners, LPInstitution
2.15%85,192 Aas of Jun 30, 2026
Aisling Capital Management LPInstitution
1.26%50,000 Aas of Jun 30, 2026
Marshall Wace, LLPInstitution
1.00%39,560 Aas of Jun 30, 2026
Geode Capital Management, LLCInstitution
0.82%32,470 Aas of Jun 30, 2026
Renaissance Technologies LLCInstitution
0.44%17,454 Aas of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution
0.41%16,239 Aas of Jun 30, 2026
BlackRock, Inc.Institution
0.37%14,731 Aas of Jun 30, 2026
Jane Street Group, LLCInstitution
0.35%13,703 Aas of Jun 30, 2026
State Street CorpInstitution
0.31%12,266 Aas of Jun 30, 2026
Two Sigma Investments, LPInstitution
0.29%11,486 Aas of Jun 30, 2026
Verdad Advisers, LPInstitution
0.23%8,996 Aas of Jun 30, 2026
Integrated Quantitative Investments LLCInstitution
0.21%8,210 Aas of Jun 30, 2026
Susquehanna International Group, LLPInstitution
0.20%8,023 Aas of Jun 30, 2026
Quadrature Capital LtdInstitution
0.16%6,305 Aas of Jun 30, 2026
Trexquant Investment LPInstitution
0.16%6,240 Aas of Jun 30, 2026
  1. Srinivas Akkaraju's transaction reports restate only vehicles that traded; the 2025 ownership statement (403.9K) is used instead.

13F, as of Jun 30, 2026

44 holders · 1.61M shares · 17 new positions · 23 increased · 7 reduced · 8 closed

HolderShares% of companyChg q/qFiled
Samsara Biocapital, LLC298.5K7.55%0Aug 14, 2026
Millennium Management LLC269.9K6.83%+63.6KAug 14, 2026
FMR LLC260.4K6.59%0Aug 13, 2026
Siren, L.L.C.163.0K4.12%0Aug 13, 2026
Baker Bros. Advisors LP148.3K3.75%0Aug 14, 2026
Vanguard Capital Management LLC94.5K2.39%−14.5KAug 13, 2026
Trails Edge Capital Partners, LP85.2K2.15%−54.4KAug 14, 2026
Aisling Capital Management LP50.0K1.26%+50.0KnewAug 13, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Srinivas Akkarajuincl. Samsara BioCapital, L.P., Samsara Opportunity Fund GP, LLC +2 more9.90%403.9K13DDec 9, 2025
Trails Edge Capital Partners, LP9.90%340.5K13GSep 8, 2025
Invus Public Equities, L.P.8.40%345.9K13GNov 12, 2025
FMR LLCincl. Abigail P. Johnson7.32%178.2KNov 12, 2024
Integrated Core Strategies (US) LLC5.00%198.7K13GApr 16, 2026
Millennium Management LLC5.00%198.2K13GMar 27, 2026

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.